By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
With about a month left until RESI Boston June 2023 and a few days before partnering launch, LSN is very excited to announce the list of 50+ finalist companies who will be participating in the Innovator’s Pitch Challenge (IPC)!
The deadline was set earlier than our usual IPC application cycles, but the RESI team still received a record number of applications.
Over 50 companies representing therapeutics, medical devices, diagnostics, digital health, and R&D / life science tools across the globe will be delivering a live pitch followed by a Q&A session with a panel of investors and industry experts. In addition, the companies will be presenting a poster showcasing their technology in the exhibit hall. We were very impressed by all of the amazing technologies developed by the IPC finalist companies and we cannot wait to showcase them at the upcoming RESI!
Below are the participating companies. If you are interested in seeing these pitches and engaging in one-on-one partnering with over 1,000 attendees expected to attend, you can register here!
RESI Boston June 2023 IPC Finalists
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Next Phase Newsletter 
Leave a comment